Michigan HB5941 requires drug manufacturers to report certain costs and information about prescription drugs to the Department of Insurance and.

Michigan HB5941, known as the "drug manufacturer data reporting act," mandates that drug manufacturers submit reports to the Department of Insurance and Financial Services. These reports must include details such as research and development costs, direct-to-consumer advertising expenses, and information about drugs approved or losing patent exclusivity in the past five years. Manufacturers must also notify the department if they introduce a new drug with a wholesale acquisition cost exceeding the Medicare Part D specialty drug threshold.

Michigan HB5941 requires drug manufacturers to report certain costs and information about prescription drugs to the Department of Insurance and.

Michigan HB5941, known as the "drug manufacturer data reporting act," mandates that drug manufacturers submit reports to the Department of Insurance and Financial Services. These reports must include details such as research and development costs, direct-to-consumer advertising expenses, and information about drugs approved or losing patent exclusivity in the past five years. Manufacturers must also notify the department if they introduce a new drug with a wholesale acquisition cost exceeding the Medicare Part D specialty drug threshold.